Macrophage responses to CF pathogens: JNK MAP kinase signaling by Burkholderia cepacia complex lipopolysaccharide

FEMS Immunology and Medical Microbiology

Volumn 60, Issue 1, 2010, Pages 36-43

  McKeon, Suzanne ^a,b   McClean, Siobhán ^a   Callaghan, Máire ^a  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b Health Sciences Centre Calgary   (Canada)

Author keywords

Burkholderia multivorans; cenocepacia; macrophage; mitogen activated protein kinase; Pseudomonas; U937

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA MULTIVORANS; CELL STRAIN U937; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERNALIZATION; MACROPHAGE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

BURKHOLDERIA CEPACIA COMPLEX; CELL LINE; CYTOKINES; CYTOPLASM; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MACROPHAGES; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

EID: 77956514957     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2010.00712.x     Document Type: Article

References (28)

1. Armstrong DS, Grimwood K, Carlin JB et al 1997) Lower airway inflammation in infants and young children with cystic fibrosis. Am J Resp Crit Care 156 : 1197 1204.
2. Baldwin A, Mahenthiralingam E, Drevinek P et al 2008) Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing. J Clin Microbiol 46 : 290 295.
3. Bamford S, Ryley H Jackson SK (2007) Highly purified lipopolysaccharides from Burkholderia cepacia complex clinical isolates induce inflammatory cytokine responses via TLR4-mediated MAPK signalling pathways and activation of NFkappaB. Cell Microbiol 9 : 532 543.
4. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H Berger M (1995) Inflammatory cytokines in cystic fibrosis lungs. Am J Resp Crit Care 152 : 2111 2118.
5. Burns JL, Jonas M, Chi EY, Clark DK, Berger A Griffith A (1996) Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun 64 : 4054 4059.
6. Cheung DO, Halsey K Speert DP (2000) Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa. Infect Immun 68 : 4585 4592.
7. Chu KK, MacDonald KL, Davidson DJ Speert DP (2004) Persistence of Burkholderia multivorans within the pulmonary macrophage in the murine lung. Infect Immun 72 : 6142 6147.
8. De Soyza A, Ellis CD, Khan CM, Corris PA Demarco de Hormaeche R (2004) Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. Am J Resp Crit Care 170 : 70 77.
9. Galanos C, Luderitz O Westphal O (1969) A new method for the extraction of R lipopolysaccharides. Eur J Biochem 9 : 245 249.
10. Ge Y, MacDonald DL, Holroyd KJ, Thornsberry C, Wexler H Zasloff M (1999) In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Ch 43 : 782 788.
11. Gibson RL, Burns JL Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Resp Crit Care 168 : 918 951.
12. Isberg RR Falkow S (1985) A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature 317 : 262 264.
13. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P Levison H (1984) Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 104 : 206 210.
14. Lamothe J, Huynh KK, Grinstein S Valvano MA (2007) Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles. Cell Microbiol 9 : 40 53.
15. Laskin DL Pendino KJ (1995) Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol 35 : 655 677.
16. Mahenthiralingam E, Vandamme P, Campbell ME et al 2001) Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis 33 : 1469 1475.
17. Mahenthiralingam E, Baldwin A Dowson CG (2008) Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J Appl Microbiol 104 : 1539 1551.
18. Martin DW Mohr CD (2000) Invasion and intracellular survival of Burkholderia cepacia. Infect Immun 68 : 24 29.
19. Ramis I, Bioque G, Lorente J et al 2000) Constitutive nuclear factor-kappaB activity in human upper airway tissues and nasal epithelial cells. Eur Respir J 15 : 582 589.
20. Riordan JR, Rommens JM, Kerem B et al 1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 : 1066 1073. (Pubitemid 19231814)
21. Saini LS, Galsworthy SB, John MA Valvano MA (1999) Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology 145 : 3465 3475.
22. Shaw D, Poxton IR Govan JR (1995) Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol Med Mic 11 : 99 106.
23. Shimomura H, Matsuura M, Saito S, Hirai Y, Isshiki Y Kawahara K (2001) Lipopolysaccharide of Burkholderia cepacia and its unique character to stimulate murine macrophages with relative lack of interleukin-1beta-inducing ability. Infect Immun 69 : 3663 3669.
24. Silipo A, Molinaro A, Ierano T et al 2007) The complete structure and pro-inflammatory activity of the lipooligosaccharide of the highly epidemic and virulent gram-negative bacterium Burkholderia cenocepacia ET-12 (strain J2315). Chemistry 13 : 3501 3511.
25. Vanlaere E, Lipuma JJ, Baldwin A et al 2008) Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int J Syst Evol Micr 58 : 1580 1590.
26. Vanlaere E, Baldwin A, Gevers D et al 2009) Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Micr 59 : 102 111.
27. Vinion-Dubiel AD Goldberg JB (2003) Lipopolysaccharide of Burkholderia cepacia complex. J Endotoxin Res 9 : 201 213.
28. Zughaier SM, Ryley HC Jackson SK (1999) Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect Immun 67 : 1505 1507.